Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 3, Supplement 1 , Pages S56-S60 , March 2008

Interventions in Chronic Pain Management. 5. Approaches to Medication and Lifestyle in Chronic Pain Syndromes

  • Mitchell K. Freedman, DO

      Affiliations

    • Rothman Institute, Philadelphia, PA
    • Corresponding Author InformationCorrespondence to Mitchell K. Freedman, DO, Rothman Institute, 925 Chestnut St, Philadelphia, PA 19107
    • ,
  • Michael F. Saulino, MD

      Affiliations

    • Moss Rehabilitation, Elkins Park, PA
    • ,
  • E. Anthony Overton, DO

      Affiliations

    • Rothman Institute, Philadelphia, PA
    • ,
  • Michele Y. Holding, MD

      Affiliations

    • The Back Pain Center, Phoenixville, PA
    • ,
  • Ira D. Kornbluth, MD

      Affiliations

    • Spine Medicine and Rehabilitation Therapies, Westminster, MD.

References 

  1. Riebel GD, Boden SD, Whitesides TE, Hutton WC. The effect of nicotine on incorporation of cancellous bone graft in an animal model. Spine. 1995;20:2198–2202
  2. Leboeuf-Yde C, Ohm Kyvik K, Henrik Bruun N. Low back pain and lifestyle (Part I. Smoking information from a population-based sample of 29,424 twins). Spine. 1998;23:2207–2214
  3. Scott SC, Goldberg MS, Mayo NE, Stock SR, Poitras B. The association between cigarette smoking and back pain in adults. Spine. 1999;24:1090–1098
  4. Kaila-Kangas L, Leio-Arjas P, Riihimk̈i H, Luukkonen E, Kirjonen J. Smoking and overweight as predictors of hospitalization of back disorders. Spine. 2003;28:1860–1868
  5. Leboeuf-Yde C. Smoking and low back pain: a systematic literature review of 41 journal articles reporting 47 epidemiologic studies. Spine. 1999;24:1463–1470
  6. Silcox DH, Daftari T, Boden SD, Schimandle JH, Hutton WC, Whitesides TE. The effect of nicotine on spinal fusion. Spine. 1995;20:1549–1553
  7. Glassman SD, Anagnost SC, Parker A, Burke D, Johnson JR, Dimar JR. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine. 2000;25:2608–2615
  8. Anderson T, Christensen FB, Laursen M, Hoy K, Hansen ES, Bunger C. Smoking as a predictor of negative outcome in lumbar spinal fusion. Spine. 2001;26:2623–2628
  9. Henningfield J. Nicotine medication for smoking cessation. N Engl J Med. 1995;333:1196–1203
  10. Cahill K, Stead L, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD006103.
  11. Sigaly C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000146.
  12. Leboeuf-Yde C, Kyvik KO, Bruun NH. Low back pain and lifestyle (Part II. Obesity. Information from a population-based sample of 29,424 twin subjects). Spine. 1999;24:779–784
  13. Pi-Sunyer FX. The medial risks of obesity. Obes Surg. 2002;12(Suppl 1):6S–11S
  14. Marcus D. Obesity and the impact of chronic pain. Clin J Pain. 2004;63:186–191
  15. Mayer T, Aceska A, Gatchel RJ. Is obesity overrated as a “risk factor” for poor outcomes in chronic occupational spinal disorders?. Spine. 2006;31:2967–2972
  16. Lake J, Power C, Cole TJ. Back pain and obesity in the 1958 British birth cohort (Cause or effect?). J Clin Epidemiol. 2000;53:245–250
  17. Hill JO, Wyatt HR. Role of physical activity in preventing and treating obesity. J Appl Physiol. 2005;99:765–770
  18. Stanton-Hicks M. Complex regional pain syndrome. Anesthesiol Clin North America. 2003;21:733–744
  19. Ribbers GM, Geurts AC, Stam HJ, Mulder T. Pharmacologic treatment of complex regional pain syndrome I: a conceptual framework. Arch Phys Med Rehabil. 2003;84:141–146
  20. Stacey BR. Management of peripheral pain. Am J Phys Med Rehabil. 2005;84(3 Suppl):S4–S16
  21. Howard PA, Delafontaine P. Nonsteroidal anti-inflammatory drugs and cardiovascular risk. J Am Coll Cardiol. 2004;43:519–525
  22. U.S. Food and Drug Administration. Concomitant use of ibuprofen and aspirin: potential for attenuation of the antiplatelet effect of aspirin. Rockville: FDA National Press Office; 2006;Sep.
  23. Dugowson CE, Gnanashanmugam P. Nonsteroidal anti-inflammatory drugs. Phys Med Rehabil Clin N Am. 2006;17:347–354
  24. Kaplan RJ. Current status of nonsteroidal anti-inflammatory drugs in physiatry: balancing risks and benefits in pain management. Am J Phys Med Rehabil. 2005;84:885–894
  25. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55:1–20
  26. Harden RN. Pharmacotherapy of complex regional pain syndrome. Am J Phys Med Rehabil. 2005;84:S17–S28
  27. Grabois M. Management of chronic low back pain. Am J Phys Med Rehabil. 2005;84:S29–S41
  28. Chou R, Peterson K, Helfand H. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004;28:140–147
  29. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther. 2004;26:1355–1367
  30. Meleger AL. Muscle relaxants and antispasticity agents. Phys Med Rehabil Clin N Am. 2006;17:401–413
  31. van de Vusse AC, Stomp-van den Berg SG, Kessels AH, Weber WE. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1. BMC Neurol. 2004;4:13
  32. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD001133.
  33. Bloodworth D. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations. Phys Med Rehabil Clin N Am. 2006;17:355–379
  34. Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil. 2005;84:S42–S55
  35. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005;(3):CD005454.
  36. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2006;(3):CD003726.
  37. Crayton H, Heyman RA, Rossman HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology. 2004;63(11 Suppl 5):S12–S18
  38. Schapiro RT. Management of spasticity, pain and paroxysmal phenomena in multiple sclerosis. Curr Neurol Neurosci Rep. 2001;1:299–302
  39. Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess. 2003;7:iii, ix-x, 1-111.
  40. Ehde DM, Osborne TL, Jensen MP. Chronic pain in persons with multiple sclerosis. Phys Med Rehabil Clin N Am. 2005;16:503–512

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

 Reprints are not available from the author.

PII: S0003-9993(07)01849-7

doi: 10.1016/j.apmr.2007.12.002

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 3, Supplement 1 , Pages S56-S60 , March 2008

Article Tools